Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 9,502

Document Document Title
WO/2012/171484A1
Disclosed is a substituted cyanoaniline compound or a salt thereof, wherein the compound has a structure represented by General Formula I. The compound of General Formula I has broad-spectrum fungicidal activity in the field of agricultu...  
WO/2012/173694A1
Embodiments are related to ionic liquids and more specifically to ionic liquids used in electrochemical metal-air cells in which the ionic liquid includes sulfonate ions as the anion.  
WO/2012/163799A1
The present invention relates to a novel enantioselective method of preparing (S)- and (R)-enantiomers of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-5 methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonami de, to novel inte...  
WO/2012/147944A1
The present invention provides a method for producing a compound represented by general formula (1) (wherein R1, R2, R3, R10-R14, A1-A3, n1 and n2 are as defined in the description), which is characterized by reacting a compound represen...  
WO/2012/147037A2
Isolation of Naphthalene Sulphonic Acid Compounds is achieved with acidification of alkali fusion mixture with dilute sulphuric acid to precipitation at the predetermined conditions temperature, time and p H and Naphthalene Sulphonic Aci...  
WO/2012/148624A1
Hydroxyamides are synthesized from esters. A process of making hydroxyalkyl amides comprises : reacting an ester with a hydroxyalkyl amine having the formula H2N-R3-OH wherein R3 is a substituted or unsubstituted C2 to C5 alkyl, in the p...  
WO/2012/147037A3
Isolation of Naphthalene Sulphonic Acid Compounds is achieved with acidification of alkali fusion mixture with dilute sulphuric acid to precipitation at the predetermined conditions temperature, time and pH and Naphthalene Sulphonic Acid...  
WO/2012/142927A1
A method for purification of calcium ion channel blocker medicament of dihydropyridine type and pharmaceutically acceptable salts thereof through the ultrasonic crystallization technology and direct preparation of nanoparticles thereof.  
WO/2012/137813A1
Provided is a method for producing a bis(perfluoroalkanesulfone)imide salt by adding water and an alkali metal hydroxide to a salt containing the bis(perfluoroalkanesulfone)imide salt represented by the general formula (RfSO2)2NM (in the...  
WO/2012/136761A1
The present invention relates to a process for the preparation of the mono sodium salt of the derivative 3,5-diiodo-O-[3-iodo-4-(sulphooxy)phenyl]-L- tyrosine (T3S) by starting from the corresponding phenolic compound, in the presence of...  
WO/2012/132269A1
The present invention provides a novel diamine compound that contains a sulfonic acid group and is represented by formula (1), and a method for producing the same. This compound has a fluorene backbone including a sulfonic acid group or ...  
WO/2012/134464A1
Disclosed is a method for improving filtration in the preparation of an alkaline earth metal alkyltoluene sulfonate concentrate by selectively controlling the meta, ortho, para isomer distribution of the alkyl group of the alkyltoluene p...  
WO/2012/126630A1
The subject matter of the present invention relates to highly-concentrated compositions of salts of alkyl polyalkoxy sulphates, whereby in total at least 2/3 of all alkoxy unit of the alkyl polyalkoxy sulphates are propoxy units, a metho...  
WO/2012/126088A1
A method for preparing docosahexaenoic acid (DHA). The method comprises coupling a compound represented by Formula I with a compound represented by Formula II followed by partial hydrogenation to obtain a compound represented by Formula ...  
WO/2012/122667A1
Betaine surfactants of formula (I) and preparation methods and uses thereof are provided. The surfactants can depress the interfacial surface tension of crude oil till 10-3mN/m, have the capabilities of antiheating (130℃), antiminerali...  
WO/2012/122667A8
Betaine surfactants of formula (I) and preparation methods and uses thereof are provided. The surfactants can depress the interfacial surface tension of crude oil till 10-3mN/m, have the capabilities of antiheating (130℃), antiminerali...  
WO/2012/117961A1
Obtain a compound [II] such as N, N-di(fluorosulfonyl)imide ammonium salt by reacting a compound [I] such as N, N-di(chlorosulfonyl)imide and NH4F(HF)p. Obtain a compound [IV] such as N, N-di(fluorosulfonyl)imide alkali metal salt by rea...  
WO/2012/118973A3
The claimed invention meets these and other objects by providing a method of preparing a metal salt of a dialkyl ester of 5-sulfoisophthalic acid. Broadly speaking, the method provides for the contacting of a dialkyl ester of 5-sulfoisop...  
WO/2012/118973A2
The claimed invention meets these and other objects by providing a method of preparing a metal salt of a dialkyl ester of 5-sulfoisophthalic acid. Broadly speaking, the method provides for the contacting of a dialkyl ester of 5-sulfoisop...  
WO/2012/112828A1
The invention is directed to mixtures comprising C10-C14 linear alkylphenyl sulfonates with alkyl groups having a biobased content of at least 50%. These C10-C14 linear alkylphenyl sulfonates are used in consumer product cleaning and per...  
WO/2012/110092A1
Pharmaceutically useful compounds of general formula (2) or of general formula (2-1) wherein R is hydrogen or a C1-C10 alkyl/aryl/aralkyl group, and R1 is a C1-C10 alkyl/aryl/aralkyl group, and Z is -0-, -S- or -NH- linkage. Processes fo...  
WO/2012/112828A4
The invention is directed to mixtures comprising C10-C14 linear alkylphenyl sulfonates with alkyl groups having a biobased content of at least 50%. These C10-C14 linear alkylphenyl sulfonates are used in consumer product cleaning and per...  
WO/2012/108284A1
A compound [I] such as an N-(chlorosulfonyl)-N-(fluorosulfonyl)imide ammonium salt is reacted with hydrogen fluoride to produce a compound [II] such as an N,N-di(fluorosulfonyl)imide ammonium salt. The resulting compound [II] is reacted ...  
WO/2012/103799A1
Disclosed are (2R,3R)-3-(3-substituted phenyl)-2-methyl-n-pentanamide compounds shown as formula I, their preparation methods thereof, wherein the substituents are described in the description, and their uses in the manufacture of Tapent...  
WO/2012/105586A1
This perfluorobutane sulfonyl fluoride has a perfluorosulfolane content of 100 ppm or less on a mass basis. This potassium perfluorobutane sulfonate salt has a potassium 1,1,2,2,3,3,4,4-octafluorobutane sulfonate salt content of 100 ppm ...  
WO/2012/099184A1
A fluoroamine can be produced by: protecting an amino group of an amino alcohol with a nitrobenzenesulfonyl group, thereby converting into a protected amino alcohol (amino group protection step); causing the protected amino alcohol to re...  
WO/2012/097550A1
Cyclohydrocarbyl formamide derivatives of general formula (I), preparation methods and uses thereof are provided. The present cyclohydrocarbyl formamide derivatives of general formula (I) target on the auxiliary protein Vif (Virus infect...  
WO/2012/097351A1
Described herein are molecules useful to affect cancer cells, along with related methods. The present compounds, formulations, kits and methods are useful for diagnostic, therapeutic and research. STAT3 inhibitors, particularly LLL12, ar...  
WO/2012/084794A1
The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabelled amino acids for use in in vivo imaging ...  
WO/2012/084831A1
The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabelled amino acids for use in in vivo imaging ...  
WO/2012/078521A1
A process comprising contacting deionized water with one or more Strecker sulfonation reaction products of one or more halogenated alkyl ethers in the presence of sulfite, wherein the one or more Strecker sulfonation reaction products ea...  
WO/2012/073249A1
Disclosed herein is an efficient and economical process for the preparation of 3-Benzyloxybenzenethiol of formula-I which is a key intermediate for the preparation of pharmaceutical drugs. R' is hydrogen, halogen, trihalomethyl, lower al...  
WO/2012/070793A3
The present invention relates to an improved method for purifying a sulfonated aromatic monomer. The method for purifying a sulfonated aromatic monomer is an economical method which is capable of obtaining the sulfonated aromatic monomer...  
WO/2012/070793A2
The present invention relates to an improved method for purifying a sulfonated aromatic monomer. The method for purifying a sulfonated aromatic monomer is an economical method which is capable of obtaining the sulfonated aromatic monomer...  
WO/2012/069004A1
Disclosed are a preparation method for a key intermediate of tapentadol: (1R, 2R)-1-ethyl-2-methylbenzene ethane compound, and a method for applying the key intermediate in the preparation of tapentadol and a derivative thereof.  
WO/2012/059436A2
The invention relates to novel compounds of formula (I), in which R1, R2, R3, R4, R5, Y, Q and G are defined as indicated above, to several methods and intermediate products for the production thereof and use thereof as herbicides and/or...  
WO/2012/054097A1
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 500 ppm sulfate. The process uses a reaction mixture of water, a lithium cation producing compound, and 5-sulfoisophthalic a...  
WO/2012/053565A1
Provided is a novel process for producing an optically active β-amino aldehyde compound from an imine compound. The present invention provides a process for producing an optically active β-amino aldehyde compound (3), which comprises a...  
WO/2012/054097A8
There is disclosed a process for making a mono-lithium salt of 5-sulfoisophthalic acid (LiSIPA) having less than 500 ppm sulfate. The process uses a reaction mixture of water, a lithium cation producing compound, and 5-sulfoisophthalic a...  
WO/2012/049345A1
The invention relates to a method for capturing isocyanides. These systems can be used in the synthesis of organic compounds, in the chemical and pharmaceutical industry and in environmentally friendly chemical processes characteristic o...  
WO/2012/045849A1
The present invention relates to a new method for the preparation of (3S,3S') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.  
WO/2012/039025A1
This process for producing a perfluoroalkylsulfonamide is characterized by reacting a perfluoroalkylsulfonyl halide or a perfluoroalkylsulfonic anhydride with ammonia water to obtain a liquid reaction mixture containing the ammonium salt...  
WO/2012/039024A1
Disclosed are a method and a device for recovering a perfluoroalkanesulfonyl fluoride, the method comprising bringing a gas consisting mainly of a perfluoroalkanesulfonyl fluoride represented by the general formula CnF2n+1SO2F (n is an i...  
WO/2012/033798A1
A process for the purification of fluoroalkanesulfonate salt comprising (a) contacting a mixture of said salt and an inorganic salt contaminant with a solvent to selectively dissolve said fluoroalkanesulfonate salt in solution, and (b) i...  
WO/2012/030181A3
The present invention relates to a compound for the preparation of a natural gas hydrate, and more specifically, to a method for using a multi-chain type surfactant having two or three hydrophobic groups and two sulfate or sulfonate grou...  
WO/2012/030181A2
The present invention relates to a compound for the preparation of a natural gas hydrate, and more specifically, to a method for using a multi-chain type surfactant having two or three hydrophobic groups and two sulfate or sulfonate grou...  
WO/2012/029411A1
Disclosed is a method for producing a biaryl compound represented by formula (2) shown below, which comprises a step wherein a compound represented by formula (1) shown below is coupled in the presence of an amine compound that has at le...  
WO/2012/027951A1
The invention relates to an intermediate used for preparation of imipenem medicine, a preparation method and use thereof. The said intermediate is shown in the structure of formula (I), wherein R1 is C1- C3 lower alkyl, nitryl, halogen, ...  
WO/2012/020513A1
This method for producing a fluorine-containing sulfonylimide compound ((Rf1SO2)(Rf2SO2)N•M) comprises: a first step of obtaining a reaction solution by reacting a perfluoroalkyl sulfonyl fluoride (Rf1SO2F) and ammonia; a second step o...  
WO/2012/010752A1
The invention relates to a process for preparing salts of formulae (RfSO3)n Xn+ (I) or [(RfSO2)(RSO2)N]nXn+ (II) in which: - Rf represents any radical comprising one or more fluorine atoms, - n is an integer varying from 1 to 6, - X is a...  

Matches 301 - 350 out of 9,502